These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4005957)

  • 1. Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.
    Lala PK; Santer V; Libenson H; Parhar RS
    Cell Immunol; 1985 Jul; 93(2):250-64. PubMed ID: 4005957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
    Lala PK; Parhar RS; Singh P
    Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity.
    Parhar RS; Lala PK
    Cell Immunol; 1985 Jul; 93(2):265-79. PubMed ID: 3159480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the maternal natural killer cell population during the course of murine pregnancy.
    Chatterjee-Hasrouni S; Parhar R; Lala PK
    Cell Immunol; 1984 Apr; 84(2):264-75. PubMed ID: 6705050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of lymphocyte subsets in spontaneous mouse mammary tumors and host lymphoid organs.
    Santer V; Mastromarino JH; Lala PK
    Int J Cancer; 1980 Jan; 25(1):159-68. PubMed ID: 6967460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the populations of null, NK1.1+, and Thy1lo lymphocytes in the bone marrow of tumor-bearing mice: effect of indomethacin treatment.
    Rahal MD; Reinish E; Osmond DG
    Cell Immunol; 1992 Jan; 139(1):218-28. PubMed ID: 1345896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tumor bearing on the dynamics of host hemopoietic cells.
    Lala PK
    Cancer Treat Rep; 1976 Dec; 60(12):1781-9. PubMed ID: 1026335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
    Khoo NK; Chan FP; Saarloos MN; Lala PK
    Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin-mediated inactivation of natural killer cells in the murine decidua.
    Scodras JM; Parhar RS; Kennedy TG; Lala PK
    Cell Immunol; 1990 May; 127(2):352-67. PubMed ID: 2139365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells in murine muscular dystrophy. IV. Characterization of Percoll fractionated splenic and thymic natural killer cells and natural killer-sensitive thymocyte targets.
    Semple JW; Szewczuk MR
    Clin Immunol Immunopathol; 1986 Oct; 41(1):116-29. PubMed ID: 3017622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced natural killer (NK) cell activity and NK-sensitive thymic cells in murine muscular dystrophy.
    Semple JW; Szewczuk MR
    Cell Immunol; 1983 Dec; 82(2):316-25. PubMed ID: 6652689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
    Hackett J; Bennett M; Kumar V
    J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
    Vujanovic NL; Herberman RB; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
    Kumar V; Luevano E; Bennett M
    J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative studies of natural immunity to solid tumours in rats. NK activity in animals with primary or transplanted spontaneous tumours.
    Flannery GR; Brooks CG
    Int J Cancer; 1981 Dec; 28(6):747-55. PubMed ID: 7333706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells.
    Riccardi C; Giampietri A; Migliorati G; Cannarile L; D'Adamio L; Herberman RB
    Int J Cancer; 1986 Oct; 38(4):553-62. PubMed ID: 2944847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of host T-cell subsets based on Lyt antigenic markers during the development of spontaneous C3H mammary carcinomas.
    Brodt P; Lala PK
    Cell Immunol; 1984 Apr; 84(2):427-32. PubMed ID: 6608412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.